Offer - Urjas Oil for just ₹ 1
Duovir E is an allopathic medicine The correct dosage of Duovir E depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Duovir E is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Is the use of Duovir E safe for pregnant women?
Duovir E can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Duovir E right away. Take your doctor's advice before taking it again.
Is the use of Duovir E safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Duovir E. Immediately discontinue Duovir E if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Duovir E on the Kidneys?
Very few cases of side effects of Duovir E on kidney have been reported.
What is the effect of Duovir E on the Liver?
Duovir E may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Duovir E on the Heart?
Duovir E has very mild side effects on the heart.
Duovir E should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Duovir E unless your doctor advises you to do so -
Is this Duovir E habit forming or addictive?
Duovir E is not addictive in nature.
Interaction between Food and Duovir E
It is safe to take Duovir E with food.
Interaction between Alcohol and Duovir E
Taking alcohol with Duovir E can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Sustiva® (efavirenz)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 481-483
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 809-810
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retrovir® (zidovudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 806-807
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1286-1288
